Jump to content [Access key 'm'] Jump to site navigation [Access key 'n'] Jump to Contact Us and Glossary [Access key 's'] Jump to Site Services and Sitemap [Access key 's'] Jump to local navigation [Access key 'l']
 

Welcome to Cyclacel

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders.

Our Commercial Products

Cyclacel’s ALIGN Pharmaceuticals subsidiary markets directly in the U.S. Xclair™ Cream for radiation dermatitis, Numoisyn™ Liquid and Numoisyn™ Lozenges for xerostomia.

Our R&D Pipeline

Applying its core strength in cell cycle biology, Cyclacel is advancing a pipeline of small molecule drugs designed to stop uncontrolled cell division. The Company has three clinical-stage compounds and a deep pipeline.

 
Copyright © 1997-2008 Cyclacel Pharmaceuticals, Inc. All Rights Reserved  |  Site Map  |  Privacy  |  Disclaimer  |  Contact Us